-+ 0.00%
-+ 0.00%
-+ 0.00%

Novo Nordisk's US stock fell more than 7% in the premarket, and its 2030 strategic target fell short of expectations.

Zhitongcaijing·09/21/2026 08:17:06
Listen to the news
Novo Nordisk's US stock fell more than 7% in the premarket, and its 2030 strategic target fell short of expectations.